New cloud-native platform enables healthcare organizations to deploy AI-ECG algorithms across their entire ECG fleet.
HeartSciences today announced the general availability of MyoVista® Insights™, a cloud-native platform that enables healthcare organizations to deploy AI-enabled ECG analysis across their entire ECG fleet.
The platform represents a significant advancement in making AI-ECG technology accessible to healthcare providers of all sizes. Unlike traditional approaches that require specific hardware or proprietary systems, MyoVista® Insights™ works with 12-lead ECG devices from major manufacturers, including GE Healthcare, Philips, Mortara, and others.
Key Platform Features
MyoVista® Insights™ includes several capabilities designed for enterprise healthcare deployment:
- Vendor-neutral device connectivity
- Multiple AI algorithms running simultaneously
- Native EHR integration via HL7 FHIR
- Real-time processing with results in under 30 seconds
- HIPAA compliance with enterprise-grade security
"We built MyoVista® Insights™ to remove the barriers that have prevented widespread adoption of AI-ECG technology," said the company's CEO. "Healthcare organizations shouldn't have to replace their ECG equipment or deal with complex integrations to benefit from AI analysis."